Evaluation of the Thoracic Revised Cardiac Risk Index as a prognostic factor for survival after lung cancer resection

T. Diaz De Teran Lopez (Santander, Spain), C. Magadan Alvarez (Santander, Spain), K. Lee (Auckland, New Zealand), P. Lozano Cuesta (Burgos, Spain), V. Maderuelo Garcia (Palencia, Spain), V. Mora Cuesta (Santander, Spain), D. Iturbe Fernandez (Santander, Spain), B. Abascal Bolado (Santander, Spain), L. Sanchez Moreno (Santander, Spain)

Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Session: Lung cancer: novel prognostic markers and scores
Session type: Thematic Poster
Number: 2798
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Diaz De Teran Lopez (Santander, Spain), C. Magadan Alvarez (Santander, Spain), K. Lee (Auckland, New Zealand), P. Lozano Cuesta (Burgos, Spain), V. Maderuelo Garcia (Palencia, Spain), V. Mora Cuesta (Santander, Spain), D. Iturbe Fernandez (Santander, Spain), B. Abascal Bolado (Santander, Spain), L. Sanchez Moreno (Santander, Spain). Evaluation of the Thoracic Revised Cardiac Risk Index as a prognostic factor for survival after lung cancer resection. 2798

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prgnostic factors in lung cancer: is preoperative Geriatric Nutritional Risk Index an independent predictive factor?
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020


Preoperative Six-Minute-Walk Test in Lung Transplantation: survival predictor
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017

Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Prognostic and predictive value of E-cathepsin for pulmonary adenocarcinomas in the IALT (International Adjuvant Lung Cancer Trial)
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival
Source: Virtual Congress 2020 – Thoracic oncology
Year: 2020


Prognostic role of PET/CT in surgically treated pN0-1 Non-Small-Cell Lung Cancer
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018


Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

Clinicopathological prognostic factors in operated for pulmonary carcinoid tumor patients
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


The prognostic value of D-dimer in lung carcinoma
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019


Daily Physical Activity as an Outcome Measure for Pulmonary Rehabilitation in Patients Undergoing Thoracoscopic Lung Cancer Surgery.
Source: International Congress 2017 – Airway clearance techniques and respiratory physiotherapy in hospitalized patients
Year: 2017


Late Breaking Abstract - Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival.
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020


Operative morbidity and mortality of different types of pneumonectomyfor lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014

Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Anxiety and depression in lung cancer patients - are there any relations to clinico-pathological characteristics?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Prognostic value of EGFR mutation in NSCLC in surgical stage
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014